These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
671 related items for PubMed ID: 19305027
1. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation]. Niedzielska E, Wójcik D, Barg E, Pietras W, Sega-Pondel D, Doroszko A, Niedzielska M, Skarzyńska M, Chybicka A. Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027 [Abstract] [Full Text] [Related]
2. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission]. Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW. Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688 [Abstract] [Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F. Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789 [Abstract] [Full Text] [Related]
4. [Analysis of some risk factors for abnormal growth velocity in children treated with haematopoetic stem cell transplantation]. Wójcik D, Barg E, Niedzielska E, Doroszko A, Kałwak K, Pietras W. Med Wieku Rozwoj; 2006 Mar; 10(3 Pt 1):841-8. PubMed ID: 17317915 [Abstract] [Full Text] [Related]
5. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia]. Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ. Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851 [Abstract] [Full Text] [Related]
6. Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors. Uehara S, Oue T, Nakahata K, Nara K, Ueno T, Owari M, Usui N, Miyamura T, Hashii Y. Eur J Pediatr Surg; 2015 Feb; 25(1):118-22. PubMed ID: 25111275 [Abstract] [Full Text] [Related]
7. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK. Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [Abstract] [Full Text] [Related]
8. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients. Kröger N, Zabelina T, Krüger W, Renges H, Stute N, Kabisch H, Jaburg N, Löliger C, Krüll A, Zander AR. Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663 [Abstract] [Full Text] [Related]
9. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Tang W, Wang L, Zhao WL, Chen YB, Shen ZX, Hu J. Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217 [Abstract] [Full Text] [Related]
10. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia]. Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY. Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032 [Abstract] [Full Text] [Related]
11. [Efficacy of allogeneic hematopoietic stem cell transplantation in treatment of childhood myelogenous leukemia: the observation of 24 cases]. Sun Y, Sun RJ, Wei ZJ, Xiao J, Zhang YC, Gao YQ, Zhu HL. Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):813-6. PubMed ID: 23302609 [Abstract] [Full Text] [Related]
12. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia]. Ma X, Wu DP, Sun AN, Fu ZZ, Tang XW, Wu XJ, Liu YJ, Qiu HY, Miao M, Han Y, Jin ZM, Zhao Y, Xue SL, Wang Y, Chen SN, He GS, Zhou HX, Chang HR. Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014 [Abstract] [Full Text] [Related]
13. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience. Hamidieh AA, Alimoghaddam K, Jahani M, Bahar B, Mousavi SA, Iravani M, Behfar M, Jalali A, Jalili M, Hamdi A, Ghavamzadeh A. J Pediatr Hematol Oncol; 2013 Aug; 35(6):e239-45. PubMed ID: 23042019 [Abstract] [Full Text] [Related]
14. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L. Ann Med; 2008 Aug; 40(6):444-55. PubMed ID: 18608121 [Abstract] [Full Text] [Related]
15. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia]. Liu QF, Fan ZP, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY. Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763 [Abstract] [Full Text] [Related]
16. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y, Li QB, Chen ZC, Li WM, Xia LH, Zhou H, Zou P. Chin Med J (Engl); 2008 Sep 20; 121(18):1770-4. PubMed ID: 19080355 [Abstract] [Full Text] [Related]
17. Clofarabine/cyclophosphamide for debulking before stem cell transplantation. Rabitsch W, Böhm A, Bojic M, Schellongowski P, Wöhrer S, Sliwa T, Keil F, Worel N, Greinix H, Hauswirth A, Kalhs P, Jaeger U, Valent P, Sperr WR. Eur J Clin Invest; 2014 Aug 20; 44(8):775-83. PubMed ID: 24942362 [Abstract] [Full Text] [Related]
18. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar 20; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
19. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Götze C, Müller-Weihrich ST, Treuner J. Bone Marrow Transplant; 1997 Feb 20; 19(3):227-31. PubMed ID: 9028550 [Abstract] [Full Text] [Related]
20. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation. Nagler A, Rocha V, Labopin M, Unal A, Ben Othman T, Campos A, Volin L, Poire X, Aljurf M, Masszi T, Socie G, Sengelov H, Michallet M, Passweg J, Veelken H, Yakoub-Agha I, Shimoni A, Mohty M. J Clin Oncol; 2013 Oct 01; 31(28):3549-56. PubMed ID: 23980086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]